Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$105,000.00

Improving the Generation of Pancreatic Beta cells from Pancreatic Multipotent Precursors for the Treatment of T1D

FY 2011-12

Summary
Type I Diabetes (T1D) results from an autoimmune attack on pancreatic beta cells causing insulin deficiency. Treatment for T1D currently involves restricted diet, blood monitoring and multiple daily injections of insulin to regulate blood sugar levels. Improvements in pancreatic beta cell transplantation has introduced new options for T1D treatment, but problems remain; low tissue availability, cell loss during isolation, allorejection and the need for chronic immunosuppression. The potential to generate beta cells from stem cells offers a large source of insulin producing cells for transplant. The proposed studies will define the current capacity of beta cell differentiation protocols, and generate strategies to improve the differentiation and expansion of adult stem cells into beta cells. Both of these steps are required before stem cell-derived beta cells represent a viable treatment for T1D.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
257527
Name
Prentice Kacey J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Improving the Generation of Pancreatic Beta cells from Pancreatic Multipotent Precursors for the Treatment of T1D
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Calcium Imaging; Development; Diabetes Mellitus; Electron Microscopy; Immunohistochemistry; Microarray; Pancreatic Beta Cells; Proteomic Analysis; Quantitative Pcr; Stem Cells
Abstract
Type I Diabetes (T1D) results from an autoimmune attack on pancreatic beta cells causing insulin deficiency. Treatment for T1D currently involves restricted diet, blood monitoring and multiple daily injections of insulin to regulate blood sugar levels. Improvements in pancreatic beta cell transplantation has introduced new options for T1D treatment, but problems remain; low tissue availability, cell loss during isolation, allorejection and the need for chronic immunosuppression. The potential to generate beta cells from stem cells offers a large source of insulin producing cells for transplant. The proposed studies will define the current capacity of beta cell differentiation protocols, and generate strategies to improve the differentiation and expansion of adult stem cells into beta cells. Both of these steps are required before stem cell-derived beta cells represent a viable treatment for T1D.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Prentice, Kacey J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~